Orange Book product · Generic (ANDA)
DICLOXACILLIN SODIUM
DICLOXACILLIN SODIUM
At a glance
Jun 03, 1982
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 03, 1982
44 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
DICLOXACILLIN SODIUM
Strength
EQ 500MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 062286
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of DICLOXACILLIN SODIUM
- —PATHOCILBrand (NDA)
NDA 050011 · WYETH AYERST
- —DYNAPENBrand (NDA)
NDA 050337 · APOTHECON
- —PATHOCILBrand (NDA)
NDA 050092 · WYETH AYERST
- 2022DICLOXACILLIN SODIUMGeneric (ANDA)
ANDA 216845 · AUROBINDO PHARMA
- —DICLOXACILLIN SODIUMGeneric (ANDA)
ANDA 061454 · CHARTWELL RX
- —DYCILLGeneric (ANDA)
ANDA 060254 · GLAXOSMITHKLINE
- —DYCILLGeneric (ANDA)
ANDA 062238 · GLAXOSMITHKLINE
- —DICLOXACILLIN SODIUMGeneric (ANDA)
ANDA 061455 · APOTHECON
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
